Epitalon

10mg Vial

50mg Vial

29 August 2026Updated 29 August 2026

Epitalon

Overview Research0 Mechanism Protocols Safety

Discussions

This is Premium content Premium

Create a free account, then upgrade to Premium or Lifetime to unlock the full research article, mechanism of action, results timeline, dosing protocol, and dose calculator for Epitalon.

Create free account Member login

Full range of benefits for Epitalon

May stimulate telomerase activity, supporting telomere maintenance

Associated with telomere length preservation in preclinical studies

May help normalize circadian rhythms and improve sleep quality

May enhance melatonin secretion and pineal gland function

Shows antioxidant effects and may support DNA repair processes

Shown neuroprotective effects and cognitive support in animal studies

May modulate immune function and reduce inflammatory markers

Linked to improved reproductive hormone balance in some studies

Associated with improved skin structure and wound healing in models

Extended lifespan and healthspan observed in certain animal studies

This peptide's combination-safety and interaction data below always stays visible, regardless of membership.

Warning

Important information. The data compiled from scientific literature is provided for educational purposes. Dosage ranges reflect what is reported in studies and do not constitute a recommendation, prescription, or usage guidance. Health decisions should always be made with a qualified professional.

Peptide Interactions

// 17 known interactions

Synergistic(4)Compatible(4)Monitor(4)Avoid(5)

Generally well-tolerated alongside this peptide

Statins

No known direct interaction with Epitalon; can generally be co-administered with routine cardiovascular monitoring.

ACE inhibitors / ARBs

Generally compatible with Epitalon with no reported pharmacologic interactions requiring adjustment.

Metformin

Commonly co-used in geroprotective regimens and has no documented direct pharmacokinetic interaction with Epitalon, though metabolic monitoring is reasonable.

Multivitamin/mineral supplements

Nutritional supplements are compatible and may support general health without known interaction with Epitalon.

All interaction categories

Synergistic (4)

Melatonin: May synergize with Epitalon for circadian regulation and sleep restoration through complementary effects on pineal function and melatonin synthesis.
NAD+ precursors (nicotinamide riboside / NMN): Support mitochondrial function and DNA repair and may complement Epitalon's proposed telomere maintenance and cellular repair effects.
Antioxidants (N-acetylcysteine, vitamin C): May enhance cellular protection by reducing oxidative stress and thereby support Epitalon’s cytoprotective actions.
Coenzyme Q10: Mitochondrial support and antioxidant properties can complement Epitalon’s cellular maintenance effects.

Compatible (4)

Statins: No known direct interaction with Epitalon; can generally be co-administered with routine cardiovascular monitoring.
ACE inhibitors / ARBs: Generally compatible with Epitalon with no reported pharmacologic interactions requiring adjustment.
Metformin: Commonly co-used in geroprotective regimens and has no documented direct pharmacokinetic interaction with Epitalon, though metabolic monitoring is reasonable.
Multivitamin/mineral supplements: Nutritional supplements are compatible and may support general health without known interaction with Epitalon.

Monitor (4)

Active malignancy / cytotoxic chemotherapy: Because Epitalon can influence telomerase activity and cell proliferation pathways, concurrent use in patients with active cancer requires oncology oversight and monitoring of tumour markers and clinical status.
Immunosuppressants (tacrolimus, cyclosporine): Potential modulation of immune function by Epitalon suggests monitoring of immunosuppressant drug levels and immune parameters when used together.
Sex hormone therapy (estrogen, testosterone): Monitor hormone levels and appropriate cancer surveillance (e.g., PSA, breast screening) as Epitalon may influence endocrine axes and cellular proliferation.
Systemic glucocorticoids: Co-administration may require monitoring of HPA axis effects and glycaemic control because of potential opposing influences on immune and endocrine regulation.

Avoid (5)

Telomerase-activating supplements/agents (e.g., TA-65): Concurrent use of other telomerase activators may have additive effects on cellular proliferation and should be evaluated for cumulative risk versus benefit, especially in those with cancer risk.
Growth hormone / GH secretagogues (sermorelin, ipamorelin): Potential additive proliferative and metabolic effects warrant careful endocrine assessment before combining with Epitalon.
Immunomodulatory biologics (anti-TNF, anti-CD20 agents): Complex immune interactions could alter therapeutic effects or risk profiles and require specialist review prior to co-administration.
Pregnancy and breastfeeding: Insufficient safety data exist for use in pregnancy or lactation, so Epitalon should generally be avoided unless clinically justified and supervised.
Uncontrolled proliferative or premalignant disorders: A history of high-grade dysplasia or other premalignant lesions requires cautious evaluation because theoretical telomerase activation could influence lesion progression.